- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
IMiG-MRI wins FDA clearance
IMiG-MRI, the joint venture between Intermagnetics General ofLatham, NY, and Surrey Medical Imaging Systems of Surrey, U.K.,has received 510(k) clearance for its IMiG-MRI 0.15-tesla permanent-magnetscanner (SCAN 7/3/96). The Food and Drug
IMiG-MRI, the joint venture between Intermagnetics General ofLatham, NY, and Surrey Medical Imaging Systems of Surrey, U.K.,has received 510(k) clearance for its IMiG-MRI 0.15-tesla permanent-magnetscanner (SCAN 7/3/96). The Food and Drug Administration's actionwill enable IMiG-MRI to begin sales of the scanner in the U.S.as well as in several Asian countries, which have effectivelymade FDA clearance a requirement for marketing, according to IMiG-MRIgeneral manager Paul Domigan.
Emerging Perspectives on PSMA PET Radiotracers: An Interview with Kenneth J. Pienta, MD
April 24th 2024In a recent interview, Kenneth J. Pienta, M.D., discussed the impact of piflufolastat F18, current directions in research with other PSMA-targeted radiotracers and future possibilities for the role of PSMA PET in the imaging paradigm for prostate cancer.
